Sign in
4/A

Changes in Ownership

NOVAVAX INC Filed Acc 0001104659-26-025366

Options or other derivatives

  • EVP, Research & Development acquired 139,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Draghia-Akli Ruxandra · EVP, Research & Development

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-02 Grant or award : show line 1 in the form Non-Statutory Stock Option NQ +139,500 139,500 D
Loading xslF345X05/tm268290-4_4aseq1.xml…